Intraperitoneal P-32 after negative second-look laparotomy in ovarian carcinoma
- 15 June 1989
- Vol. 63 (12) , 2434-2437
- https://doi.org/10.1002/1097-0142(19890615)63:12<2434::aid-cncr2820631211>3.0.co;2-b
Abstract
Thirty-one patients underwent a negative second-look laparotomy between 1976 and 1986. Fourteen patients received intraperitoneal chromic phosphate (P-32) after a negative second-look laparotomy. There has been no local recurrence (zero of 14) and no deaths attributable to recurrent disease. Local control and disease-free survival are 100%, with a minimum follow-up of 2 years and a mean follow-up of 4 years. Seventeen patients received no further therapy because of patient refusal, poor diffusion, or other contraindications to P-32 installation. Four of 17 patients undergoing negative second-look procedures without the addition of P-32 have subsequently recurred. This difference is highly suggestive (P =.076). There have been no major complications with the addition of P-32. The use of intraperitoneal P-32 after negative second-look laparotomies on ovarian carcinoma is well tolerated and effective in preventing recurrence.This publication has 6 references indexed in Scilit:
- Ovarian CarcinomaArchives of Surgery, 1986
- Prognosis of surgically determined complete responders in advanced ovarian cancerCancer, 1985
- Second-look laparotomy in the management of gynecologic malignancyGynecologic Oncology, 1982
- Radiocolloids in the Treatment of Ovarian CancerObstetrical & Gynecological Survey, 1979
- Second-look operation in ovarian carcinoma.PostchemotherapyCancer, 1976
- Radioactive colloidal chromic phosphate in the treatment of ovarian malignanciesAmerican Journal of Obstetrics and Gynecology, 1969